Mahana Therapeutics, a leading provider of prescription digital therapeutics, announced today that the company has entered into a multi-million-dollar distribution and marketing partnership with the Consumer Health division of Bayer to commercialize digital therapeutics. Earlier this year, Bayer announced the launch of a new business unit focused on delivering new digitally enabled precision health products to market.

Health technology trade association ABHI has announced that specialist marketing, PR and communications agency Highland Marketing has joined its membership.

Highland Marketing has worked with technology providers throughout the health and care sector for more than two decades, helping to bring innovations to market and raise awareness of the positive impact technologies enable for clinical teams and patients.

Frimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs).

qXR, a CE class IIb MDR cleared solution developed by Qure, was deployed with the hypothesis to categorise normal x-rays - approximately 40% of the caseload from GP and outpatient requests - and augment overall reporting efficiency.

The Department of Health and Social Care has just published a strategy for medical technology. The Highland Marketing advisory board asked what chief information officers need to know about it; and how they can make the most of the opportunities that will come from integrating device data with medical records.

NHS Fife is working with Buddy Healthcare on a digital pre-op pathway, so orthopaedic patients can complete assessments on an app and clinicians can use the data to make the best possible use of outpatient clinic and theatre time.

The Scottish health board has adopted the digital platform, which it calls ELSIE (the Electronic Pre-Operative Assessment App).

A new microperspective in the ACS journal Medicinal Chemistry Letters evaluates recent research on artificial intelligence (AI)-generated molecular structures from the point of view of the medicinal chemist and recommends guidelines for assessing the novelty and validity of these compounds.

NHS technology provider C2-Ai has been recognised at four high-profile UK healthcare and technology awards on a single night, after surgical teams across dozens of hospitals delivered significant impact for patients on waiting lists.

Surgeons say they are revolutionising how NHS waiting lists are managed with the help of the UK company’s technology, which is providing staff with an unprecedented understanding of the risks facing every individual patient.